Festive Session Sees Broad Gains, While Benchmark Momentum Cools
A positive Muhurat session brought gains across market segments, but the benchmarks had eased from their intraday highs in the available updates.
Indian equities traded higher during the Muhurat session on Sunday, with the Nifty near 25,000 and midcap and smallcap indices advancing more than 1%. Pharma and healthcare shares led sector gains, while several companies reporting higher September-quarter profits saw sharp moves.
Benchmarks stay positive after trimming gains
The Sensex and Nifty remained in the green during the special trading session, though the benchmark advance had moderated in the afternoon updates. At 2:29 p.m., the Sensex was up 104.36 points, or 0.13%, at 81,132.38. Five minutes later, the Nifty 50 stood at 25,068.80, up 38.45 points, or 0.15%.
The session headline put the Sensex about 200 points below its high, indicating that some of the early or intraday advance had been given back. These are snapshots from a live session, not closing levels. The distinction matters: a positive reading shows that buyers were still in control at those points, while the retreat from the high suggests the move was not uninterrupted.
Midcaps, smallcaps and healthcare shares broaden the advance
The session’s gains extended beyond the headline indices: the midcap and smallcap indices were reported up more than 1%. Pharma and healthcare were among the leading sectors, with Divi’s Laboratories, Wockhardt and Sun Pharmaceutical Industries among the top Nifty Pharma gainers. The sector strength gives the session a broader profile than a rally concentrated only in large-cap benchmarks.
That breadth is a useful description of the day, but it does not by itself establish a lasting change in risk appetite. The available updates do not provide closing breadth, trading volumes or institutional flows. Investors should therefore treat the gains as a session-level signal rather than evidence that smaller companies or healthcare stocks have entered a sustained uptrend.
Quarterly results put individual stocks in focus
Company-specific earnings were a prominent driver of several moves. Tata Steel rose 3.16% to ₹192.12 after reporting a 58% year-on-year increase in net profit to ₹3,666 crore for the September quarter, or Q2FY27. Divi’s Laboratories climbed 6.10% to an intraday high of ₹10,950 as consolidated net profit rose 64% to ₹1,127 crore.
Finolex Cables gained 14.12% to ₹1,245 after consolidated net profit increased 68% to ₹273 crore. The sharp share moves accompanied the reported profit growth, but the updates do not include revenue, margins or forward guidance. A single profit comparison therefore cannot show whether the performance is repeatable or fully reflected in valuations; investors would need to assess the wider results before drawing conclusions.
Global cues were mixed, leaving the session’s signal nuanced
Overseas markets offered no uniform lead: the Dow Jones fell 0.5% on Friday, while the Nasdaq rose more than 1% and the S&P 500 gained 0.3%. Against that backdrop, domestic shares advanced, but the easing of benchmark gains and the stronger performance in midcaps and smallcaps point to different currents within the market.
For investors, the more useful follow-through will be whether market breadth and sector leadership persist beyond the special session, and whether company earnings support the moves in individual shares. The live updates do not establish either outcome. The Nifty’s position around 25,000 is a prominent reference point in the session, not a guarantee of the market’s next direction.
Key Highlights
- The Sensex and Nifty were higher in afternoon snapshots, with the Nifty at 25,068.80.
- The Sensex was 104.36 points higher at 81,132.38 at 2:29 p.m., while the session headline said it was about 200 points off its high.
- Midcap and smallcap indices advanced more than 1% in the Muhurat session.
- Pharma and healthcare shares led sector gains; Divi’s Laboratories was among the notable advancers.
- Tata Steel, Divi’s Laboratories and Finolex Cables reported year-on-year September-quarter profit growth alongside share gains.
Investor Note: The session showed positive participation across several market segments, but one trading window cannot confirm a durable trend. Investors may want to distinguish broad index moves from earnings-led stock reactions and review complete company results before acting on sharp price changes.
Stay Ahead of the Market 📈
Subscribe to our weekly newsletter
Get your weekly market summary from FinBrooks Insights and smart financial lessons from FinBrooks Academy delivered straight to your inbox every weekend!